73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Curbing blood cancers by teaching immune cells to kill mutant stem cells

Curbing blood cancers by teaching immune cells to kill mutant stem cells

by Nancy Fliesler,Children's Hospital BostonROS and TLR3 signaling mediates the "eat-me" and "don't eat me" signals that determine stem cell clonal selection by macro

Curbing blood cancers by teaching immune cells to kill mutant stem cells

by Nancy Fliesler,Children's Hospital BostonROS and TLR3 signaling mediates the "eat-me" and "don't eat me" signals that determine stem cell clonal selection by macro
Immunotherapy improves survival in metastatic or recurrent head and neck cancer

Immunotherapy improves survival in metastatic or recurrent head and neck cancer

byEuropean Society for Medical OncologyProf Barbara Burtness, Yale School of Medicine and Co-Director, Development Therapeutics Research Program, Yale Cancer Center, New Haven, US, study author.

Immunotherapy improves survival in metastatic or recurrent head and neck cancer

byEuropean Society for Medical OncologyProf Barbara Burtness, Yale School of Medicine and Co-Director, Development Therapeutics Research Program, Yale Cancer Center, New Haven, US, study author.
An anticancer drug opens a new path for the treatment of Parkinson's

An anticancer drug opens a new path for the treatment of Parkinson's

by Spanish National Research CouncilGraphical abstract. Credit:Cell Chemical Biology(2024). DOI: 10.1016/j.chembiol.2024.01.007Once they enter the body, drugs, apart from carrying out

An anticancer drug opens a new path for the treatment of Parkinson's

by Spanish National Research CouncilGraphical abstract. Credit:Cell Chemical Biology(2024). DOI: 10.1016/j.chembiol.2024.01.007Once they enter the body, drugs, apart from carrying out
Study reveals how stem cells respond to environmental signals, with implications for IBD and colorectal cancer

Study reveals how stem cells respond to environmental signals, with implications for IBD and colorectal cancer

byThe Hospital for Sick ChildrenModel for PIEZO mechanosensing of the ISC niche. Credit:Science(2024). DOI: 10.1126/science.adj7615A new study from The Hospital for Sick Children (Si

Study reveals how stem cells respond to environmental signals, with implications for IBD and colorectal cancer

byThe Hospital for Sick ChildrenModel for PIEZO mechanosensing of the ISC niche. Credit:Science(2024). DOI: 10.1126/science.adj7615A new study from The Hospital for Sick Children (Si
Does eating processed meats cause colorectal cancer?

Does eating processed meats cause colorectal cancer?

by Maddie Massy-Westropp,University of New South WalesCredit: Pixabay/CC0 Public DomainThey're integral to summer, as ubiquitous as a zinced-up nose or a backyard cricket game. From December

Does eating processed meats cause colorectal cancer?

by Maddie Massy-Westropp,University of New South WalesCredit: Pixabay/CC0 Public DomainThey're integral to summer, as ubiquitous as a zinced-up nose or a backyard cricket game. From December
Study points to novel method for early diagnosis of cachexia in lung cancer patients

Study points to novel method for early diagnosis of cachexia in lung cancer patients

by Ricardo Muniz,FAPESPCachexia classification models.ADecision tree generated using Classification And Regression Trees (CART). The bottom boxes indicate hazard ratios, the number o

Study points to novel method for early diagnosis of cachexia in lung cancer patients

by Ricardo Muniz,FAPESPCachexia classification models.ADecision tree generated using Classification And Regression Trees (CART). The bottom boxes indicate hazard ratios, the number o
FDA Approves Lymphir: A New Hope for CTCL Patients

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.
Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

byTranslational Genomics Research InstituteUltrasound administration setup and drug dosing timeline. A. Photograph of the ultrasound administration setup; B. Schematic depiction of the ultrasoun

Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

byTranslational Genomics Research InstituteUltrasound administration setup and drug dosing timeline. A. Photograph of the ultrasound administration setup; B. Schematic depiction of the ultrasoun
High BMI may improve cancer survival

High BMI may improve cancer survival

byFlinders UniversityDr. Ganessan Kichenadasse from the Flinders Centre for Innovation in Cancer, South Australia. Credit: Flinders UniversityAbove average or high BMI—often linked to cancers, d

High BMI may improve cancer survival

byFlinders UniversityDr. Ganessan Kichenadasse from the Flinders Centre for Innovation in Cancer, South Australia. Credit: Flinders UniversityAbove average or high BMI—often linked to cancers, d
When cells cycle fast, cancer gets a jumpstart

When cells cycle fast, cancer gets a jumpstart

byYale UniversityCredit: CC0 Public DomainThe progression of cancer has been studied extensively, and the key steps in this journey have been well mapped, at least in some solid tumors: Lesions

When cells cycle fast, cancer gets a jumpstart

byYale UniversityCredit: CC0 Public DomainThe progression of cancer has been studied extensively, and the key steps in this journey have been well mapped, at least in some solid tumors: Lesions
Estrogen may facilitate the growth of liver metastases in non-sex-specific cancers

Estrogen may facilitate the growth of liver metastases in non-sex-specific cancers

byMcGill UniversityCancer cell during cell division. Credit: National Institutes of HealthIt is known that the tumor microenvironment plays an important role in the progression of cancer. But co

Estrogen may facilitate the growth of liver metastases in non-sex-specific cancers

byMcGill UniversityCancer cell during cell division. Credit: National Institutes of HealthIt is known that the tumor microenvironment plays an important role in the progression of cancer. But co